Offer - Urjas Oil for just ₹ 1 X
GANATON OD Tablet SR, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Indigestion. GANATON OD Tablet SR also has some secondary and off-label uses. These are listed below.
The right dosage of GANATON OD Tablet SR depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, GANATON OD Tablet SR can also lead to other problems, which have been listed below. Such side effects of GANATON OD Tablet SR normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, GANATON OD Tablet SR's effect is Unknown during pregnancy and Unknown for lactating mothers. It is important to know if GANATON OD Tablet SR has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the GANATON OD Tablet SR related warnings section.
The section on GANATON OD Tablet SR contraindications lists all such conditions.
Drug interactions for GANATON OD Tablet SR have been reported in the medical literature. See below for a complete list.
You should also be aware that GANATON OD Tablet SR is not safe while driving, and is not addiction.
GANATON OD Tablet SR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of GANATON OD Tablet SR safe for pregnant women?
No research has not been done till date on the safety of Ganaton for pregnant women. So its effects on pregnant women are unknown.
Is the use of GANATON OD Tablet SR safe during breastfeeding?
Information about safety of Ganaton for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of GANATON OD Tablet SR on the Kidneys?
Information about safety of Ganaton for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of GANATON OD Tablet SR on the Liver?
Side effects of Ganaton on the liver are unknown because research on this has not been conducted yet.
What is the effect of GANATON OD Tablet SR on the Heart?
There is no research available on the side effects of Ganaton on the heart. Therefore, its impact is unknown.
GANATON OD Tablet SR should not be taken with following medicines due to severe side effects it may cause to patients -
Mild
If you are suffering from any of the following diseases, you should not take GANATON OD Tablet SR unless your doctor advises you to do so -
Is this GANATON OD Tablet SR habit forming or addictive?
No, you will not get addicted to GANATON OD Tablet SR.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking GANATON OD Tablet SR as you may feel sleepy.
Is it safe?
Yes, but take GANATON OD Tablet SR only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking GANATON OD Tablet SR for mental disorders.
Interaction between Food and GANATON OD Tablet SR
Eating certain foods may increase the time it takes GANATON OD Tablet SR to have an effect. You should consult your doctor about it.
Interaction between Alcohol and GANATON OD Tablet SR
Information about the interaction of GANATON OD Tablet SR and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 667-668